Tissue engineering is a potentially powerful method to treat diabetes, heart failure and liver disease. Present tissue engineering approaches generally involve seeding cells onto biodegradable polymeric scaffolds. Current limitations with tissue engineering scaffolds include their inability to generate vascularized tissues, uniformly seed cells throughout the constructs, or mimic the complex cellular microenvironment. We hypothesize that by using the principles of life science, biomaterials science, and microengineering, it will be possible to develop 3D tissue-engineered constructs with controlled microvasculature and tissue architecture. We intend to use cell-laden hydrogels for fabricating microengineered tissue constructs, and to examine the functionality and applicability of these constructs by using cadiomyocytes as a tissue model. We propose a 3-step strategy to accomplish this task. Firstly, we will develop novel hydrogels comprised of natural and biodegradable materials with improved mechanical properties and favorable to cell-encapsulation. Then, we will investigate approaches to engineer the microvasculature within these hydrogels by fabricating an interconnected network of microchannels and macropores. Lastly, we will incorporate additional complexity into the cell-laden hydrogels to generate 3D tissues and replicate the cellular microenvironment.
The specific aims of our project are: 1. To develop methods for fabricating biodegradable hydrogels with controlled mechanical, chemical and biological properties for microscale tissue engineering applications;2. To engineer tissue constructs using cell-laden hydrogels incorporated with a microvasculature comprising of an interconnected network of microchannels and macropores;3. To engineer biological complexity within the microfabricated cell-laden scaffolds to generate functional 3D cardiac tissue constructs. Public Health Relevance Statement (provided by applicant): The development of a novel microscale 3D vascularized tissue engineered constructs have tremendous potential applications in the treatment of many different disease, including heart diseases. We will develop 3D tissues using novel hydrogels and provide vasculature to supply nutrients to the engineered tissue.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL092836-02
Application #
7618463
Study Section
Special Emphasis Panel (ZEB1-OSR-D (J1))
Program Officer
Lundberg, Martha
Project Start
2008-05-01
Project End
2013-03-31
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
2
Fiscal Year
2009
Total Cost
$436,904
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Yue, Kan; Liu, Yanhui; Byambaa, Batzaya et al. (2018) Visible light crosslinkable human hair keratin hydrogels. Bioeng Transl Med 3:37-48
Saghazadeh, Saghi; Rinoldi, Chiara; Schot, Maik et al. (2018) Drug delivery systems and materials for wound healing applications. Adv Drug Deliv Rev 127:138-166
Shin, Su Ryon; Kilic, Tugba; Zhang, Yu Shrike et al. (2017) Label-Free and Regenerative Electrochemical Microfluidic Biosensors for Continual Monitoring of Cell Secretomes. Adv Sci (Weinh) 4:1600522
Cheng, Hao; Yue, Kan; Kazemzadeh-Narbat, Mehdi et al. (2017) Mussel-Inspired Multifunctional Hydrogel Coating for Prevention of Infections and Enhanced Osteogenesis. ACS Appl Mater Interfaces 9:11428-11439
Massa, Solange; Sakr, Mahmoud Ahmed; Seo, Jungmok et al. (2017) Bioprinted 3D vascularized tissue model for drug toxicity analysis. Biomicrofluidics 11:044109
Leijten, Jeroen; Seo, Jungmok; Yue, Kan et al. (2017) Spatially and Temporally Controlled Hydrogels for Tissue Engineering. Mater Sci Eng R Rep 119:1-35
Yue, Kan; Li, Xiuyu; Schrobback, Karsten et al. (2017) Structural analysis of photocrosslinkable methacryloyl-modified protein derivatives. Biomaterials 139:163-171
Hjortnaes, Jesper; Goettsch, Claudia; Hutcheson, Joshua D et al. (2016) Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation. J Mol Cell Cardiol 94:13-20
Shin, Su Ryon; Zhang, Yu Shrike; Kim, Duck-Jin et al. (2016) Aptamer-Based Microfluidic Electrochemical Biosensor for Monitoring Cell-Secreted Trace Cardiac Biomarkers. Anal Chem :
Bersini, Simone; Yazdi, Iman K; Talò, Giuseppe et al. (2016) Cell-microenvironment interactions and architectures in microvascular systems. Biotechnol Adv 34:1113-1130

Showing the most recent 10 out of 150 publications